WAYNE, Pa., May 18 /PRNewswire/ -- Escalon Medical Corp. (Nasdaq: ESMC)
today announced that it has partnered with MegaVision, Inc. to form Escalon
Medical Imaging, LLC to commercialize and market a best-in-class digital
camera system for use by ophthalmologists.  MegaVision is a Santa Barbara,
Calif. based designer and manufacturer of high-end digital cameras and
accessories for professional photographers.
    Ophthalmologists routinely use photography as a diagnostic tool to detect
problems in the retinas of diabetic and elderly patients as well as in laser
surgery.  The digital cameras produced by MegaVision offer high-resolution
imaging that is superior to cameras that use conventional film.  This
high-resolution picture is the result of a chip that provides 2,000 by 3,000
line resolution as well as superior image processing and capture.
    Escalon Chairman and Chief Executive Officer, Richard J. DePiano,
commented, "We are excited to add MegaVision's digital cameras to our growing
portfolio of ophthalmic product offerings.  The higher quality images produced
by this camera can be easily viewed through a personal computer for analysis
and then stored electronically.  The camera also facilitates the detection of
retinal disorders.  The ability to obtain an instant, high-resolution image
means that patients can be examined, diagnosed, and treated in the same visit.
This will not only result in improved patient satisfaction and outcomes but
will reduce costs as well."
    Mark Maio, President of Escalon Medical Imaging, LLC added, "The
ophthalmic digital imaging system is currently in the alpha testing phase at
two universities in their respective ophthalmology departments.  We look
forward to installing the system at multiple beta sites later this year."

    About MegaVision
    The inventor of the first commercial digital camera, among other digital
photography "firsts," MegaVision has been a designer and manufacturer of
high-end digital cameras and accessories since 1983.

    About Escalon Medical
    Founded in 1987, Escalon develops, markets and distributes ophthalmic
diagnostic, surgical and pharmaceutical products as well as vascular access
devices.  The Company utilizes strategic partnerships to help finance its
development programs and is also seeking acquisitions to further diversify its
product line to achieve critical mass in sales and take better advantage of
the Company's distribution capabilities.  Escalon has headquarters in Wayne,
Pennsylvania and manufacturing operations in Long Island, New York and near
Milwaukee, Wisconsin.
    Note:  This press release contains statements that are forward-looking,
including statements about the Company's future prospects.  They are based on
the Company's current expectations and are subject to a number of
uncertainties and risks.  Actual results may be affected by, among other
things, uncertainties related to recent acquisitions, uncertainties and risks
related to new product development and introduction cycles, research and
development activities, including failure to demonstrate clinical efficacy,
delays by regulatory authorities, scientific and technical advances by the
Company or third parties, introduction of competitive products, third party
reimbursement and physician training.  Further information about these and
other relevant risks and uncertainties may be found in the Company's report on
Form 10-K, and its other filings with the Securities and Exchange Commission,
all of which are available from the Commission as well as other sources.

    To receive additional information on Escalon Medical Corp., via fax, at no
charge, dial 1-800-PRO-INFO and enter code ESMC.

Link to this page: